# Decline in Renal Concentration Ability in Lithium Treated Patients

> **NCT05307042** · — · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 51 (estimated)

## Conditions studied

- Lithium Toxicities
- Bipolar Disorder
- Concentration Ability Impaired
- Nephrogenic Diabetes Insipidus
- Lithium - Induced Nephropathy

## Interventions

- **DIAGNOSTIC_TEST:** Deamino Arginine Vasopressin (dDAVP)

## Key facts

- **NCT ID:** NCT05307042
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2022-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05307042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05307042, "Decline in Renal Concentration Ability in Lithium Treated Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05307042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*